Menu

Generate Biomedicines, Inc. GENB

Full chart Compare
Set alert

Price alert · GENB

All alert types
14.18 USD +1.12 (+8.58%)

At closeNov 9, 2026, 4:26 PM EST

14.18 0.00 0.00%

After hours · Nov 9, 4:26 PM ET

12.93 Day range 14.38
11.00 52-week range 22.67
YTD
+12.09%
1 year
+12.09%

Revenue & Expenses

Other Income → Expenses: $33.21MExpenses → Selling, General & Admin: $42.26MExpenses → Research & Development: $224.70MExpenses → Interest Expense: $1.14MExpenses → Income Tax: $163.00KGross Profit → Expenses: $31.89MRevenue → Gross Profit: $31.89MNet Loss → Expenses: $203.15MOther Income$33.21MGross Profit$31.89MNet Loss$203.15MExpenses$268.26MSelling, General & Admin$42.26MResearch & Development$224.70MInterest Expense$1.14MIncome Tax$163.00KRevenue$31.89M

Latest period ending Dec 31, 2025 · select a line to chart its full history

GENB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
31.89M20.46M
31.89M20.46M
-235.06M-196.94M
-203.15M-173.77M
-7.57-6.66
GENB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
121.99M177.70M
330.18M518.26M
141.55M163.50M
68.53M76.97M
-608.73M-433.95M
GENB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-200.62M-117.75M
116.77M-57.73M
28.06M91.33M
-3.51M-3.44M
-55.79M-84.15M